{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:50:39Z","timestamp":1740138639860,"version":"3.37.3"},"reference-count":7,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2025,1,2]]},"DOI":"10.1080\/14712598.2024.2426637","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T09:24:01Z","timestamp":1730885041000},"page":"133-138","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Pooled safety analysis from the VOLTAIRE clinical trials of adalimumab-adbm and adalimumab reference product in patients with rheumatoid arthritis, Crohn\u2019s disease, and chronic plaque psoriasis"],"prefix":"10.1080","volume":"25","author":[{"given":"Stanley","family":"Cohen","sequence":"first","affiliation":[{"name":"Metroplex Clinical Research Center, Dallas, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun","family":"Bender","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3544-4766","authenticated-orcid":false,"given":"Amy","family":"Shaberman","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Vinisko","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dottie","family":"McCabe","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"e_1_3_7_2_1","unstructured":"FDA. Guidance for industry: scientific considerations in demonstrating biosimilarity to a reference product [Internet]. 2015 [cited 2024 Jan 25]. Available from: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM291128.pdf"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212245"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2019.1645114"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00252-1"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2021.1851362"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00708-w"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2024.30.2.175"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2024.2426637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:02:46Z","timestamp":1735776166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2024.2426637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,2]]}},"alternative-id":["10.1080\/14712598.2024.2426637"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2024.2426637","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"type":"print","value":"1471-2598"},{"type":"electronic","value":"1744-7682"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-08-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}